Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shamir R Mehta

Showing results (21-30 of 212) with videos related to

Pageof 22
Sort By:
Medgenmed : Medscape General Medicine|December 22, 2005
Aspirin resistance and its implications in clinical practiceJohn Eikelboom, Mark Feldman, Shamir R Mehta, et al.
The Canadian Journal of Cardiology|March 1, 2022
The Evolution of Antiplatelet Therapy After Percutaneous Coronary Interventions: A 40-Year JourneyGuillaume Marquis-Gravel, Maxime Robert-Halabi, Kevin R Bainey, et al.
The Canadian Journal of Cardiology|November 7, 2007
Cost-effectiveness of clopidogrel in acute coronary syndromes in Canada: a long-term analysis based on the CURE trialPaul Kolm, Yong Yuan, Emir Veledar, et al.
The Canadian Journal of Cardiology|March 10, 2015
Cost implication of an early invasive strategy on weekdays and weekends in patients with acute coronary syndromesAndre Lamy, Wesley R Tong, Kevin Bainey, et al.
The American Journal of Cardiology|March 17, 2004
Incidence, predictors, and clinical significance of troponin-I elevation without creatine kinase elevation following percutaneous coronary interventionsMadhu K Natarajan, Catherine Kreatsoulas, James L Velianou, et al.
Canadian Journal of Physiology and Pharmacology|March 11, 2005
Congestive heart failure complicating non-ST segment elevation acute coronary syndrome: incidence, predictors, and clinical outcomesShamir R Mehta, John W Eikelboom, Catherine Demers, et al.
Circulation|August 16, 2006
Adverse impact of bleeding on prognosis in patients with acute coronary syndromesJohn W Eikelboom, Shamir R Mehta, Sonia S Anand, et al.
Circulation|December 14, 2005
Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis of the randomized trialsJohn W Eikelboom, Daniel J Quinlan, Shamir R Mehta, et al.
Circulation|August 18, 2004
Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) TrialKeith A A Fox, Shamir R Mehta, Ron Peters, et al.
JAMA|January 27, 2005
Effects of reviparin, a low-molecular-weight heparin, on mortality, reinfarction, and strokes in patients with acute myocardial infarction presenting with ST-segment elevationSalim Yusuf, Shamir R Mehta, Changchun Xie, et al.
Pageof 22

Showing results (21-30 of 212) with videos related to

Sort By:
Pageof 22
Medgenmed : Medscape General Medicine|December 22, 2005
Aspirin resistance and its implications in clinical practiceJohn Eikelboom, Mark Feldman, Shamir R Mehta, et al.
The Canadian Journal of Cardiology|March 1, 2022
The Evolution of Antiplatelet Therapy After Percutaneous Coronary Interventions: A 40-Year JourneyGuillaume Marquis-Gravel, Maxime Robert-Halabi, Kevin R Bainey, et al.
The Canadian Journal of Cardiology|November 7, 2007
Cost-effectiveness of clopidogrel in acute coronary syndromes in Canada: a long-term analysis based on the CURE trialPaul Kolm, Yong Yuan, Emir Veledar, et al.
The Canadian Journal of Cardiology|March 10, 2015
Cost implication of an early invasive strategy on weekdays and weekends in patients with acute coronary syndromesAndre Lamy, Wesley R Tong, Kevin Bainey, et al.
The American Journal of Cardiology|March 17, 2004
Incidence, predictors, and clinical significance of troponin-I elevation without creatine kinase elevation following percutaneous coronary interventionsMadhu K Natarajan, Catherine Kreatsoulas, James L Velianou, et al.
Canadian Journal of Physiology and Pharmacology|March 11, 2005
Congestive heart failure complicating non-ST segment elevation acute coronary syndrome: incidence, predictors, and clinical outcomesShamir R Mehta, John W Eikelboom, Catherine Demers, et al.
Circulation|August 16, 2006
Adverse impact of bleeding on prognosis in patients with acute coronary syndromesJohn W Eikelboom, Shamir R Mehta, Sonia S Anand, et al.
Circulation|December 14, 2005
Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis of the randomized trialsJohn W Eikelboom, Daniel J Quinlan, Shamir R Mehta, et al.
Circulation|August 18, 2004
Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) TrialKeith A A Fox, Shamir R Mehta, Ron Peters, et al.
JAMA|January 27, 2005
Effects of reviparin, a low-molecular-weight heparin, on mortality, reinfarction, and strokes in patients with acute myocardial infarction presenting with ST-segment elevationSalim Yusuf, Shamir R Mehta, Changchun Xie, et al.
Pageof 22